40 years on, breast cancer drug shows potential to repair myelin

A drug that is a well-established treatment for breast cancer now looks set to be a new remyelination therapy for MS. Tamoxifen has been used to treat breast cancer since the early 1970s, but University of Cambridge, UK, researchers have found some previously unknown benefits of the treatment. Dr Mark Kotter, who led the project, … Continue reading 40 years on, breast cancer drug shows potential to repair myelin